Methylergonovine Maleate recalls
Methylergonovine Maleate products have been recalled 2 times, most recently on 1 Jul 2026. The recalling company is usually Amneal Pharmaceuticals of New York. The most common reason is potency & assay.
Total recalls2since 2024
Last 12 months1reported
Class I00% of total
Ongoing1latest 1 Jul 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why methylergonovine maleate is recalled
Companies
By year
Ongoing methylergonovine maleate recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Carton Label: Major, Methylergonovine Maleate Tablets recalledMethylergonovine Maleate | The Harvard Drug Group | Potency & Assay | Nationwide |
All methylergonovine maleate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Carton Label: Major, Methylergonovine Maleate Tablets recalledMethylergonovine Maleate | The Harvard Drug Group | Potency & Assay | Nationwide |
| Drug | CLASS II | Methylergonovine Maleate Tablets, USP, 2mg recalledMethylergonovine Maleate | Amneal Pharmaceuticals of New York | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.